Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Biomed Inform. 2012 May 9;45(5):992–998. doi: 10.1016/j.jbi.2012.04.010

Table 4. Macro-Averaged F1 on I2B2 2008 Test Set.

Disease Word Imputed Cui Lin superlin Ambert

Asthma 0.970 0.970 0.970 0.970 0.970 0.970
CAD 0.631 0.624 0.621 0.618 0.618 0.630
CHF 0.615 0.601 0.607 0.601 0.612 0.612
Depression 0.963 0.976 0.979 0.982 0.979 0.935
Diabetes 0.945 0.959 0.957 0.958 0.960 0.915
Gallstones 0.954 0.950 0.950 0.942 0.950 0.961
GERD 0.578 0.579 0.579 0.579 0.579 0.579
Gout 0.982 0.982 0.982 0.982 0.982 0.981
Hypercholesterolemia 0.901 0.903 0.901 0.896 0.908 0.912
Hypertension 0.926 0.920 0.926 0.929 0.929 0.899
Hypertriglyceridemia 0.902 0.939 0.913 0.913 0.928 0.876
Osteoarthritis 0.613 0.608 0.617 0.604 0.604 0.631
Obesity 0.972 0.972 0.972 0.972 0.972 0.973
OSA 0.659 0.659 0.659 0.653 0.656 0.653
PVD 0.586 0.603 0.606 0.587 0.606 0.623
Venous Insufficiency 0.757 0.788 0.816 0.801 0.816 0.725
Macro-F1 0.6339 0.6345 0.6354 0.6330 0.6355 0.6344
Micro-F1 0.9573 0.9581 0.9593 0.9561 0.9594 0.9558

Best scores from our study indicated in bold.

Abbreviations: CAD-Coronary Artery Disease, CHF-Congestive Heart Failure, GERD-Gastroesophogeal Reflux Disease, OSA-Obstructive Sleep Apnea, PVD-Peripheral Vascular Disease.